118.10
-3.23(-2.66%)
Currency In USD
| Previous Close | 121.33 |
| Open | 122.26 |
| Day High | 122.32 |
| Day Low | 118 |
| 52-Week High | 182.52 |
| 52-Week Low | 102.97 |
| Volume | 598,954 |
| Average Volume | 771,798 |
| Market Cap | 6.64B |
| PE | -281.19 |
| EPS | -0.42 |
| Moving Average 50 Days | 126.4 |
| Moving Average 200 Days | 140.88 |
| Change | -3.23 |
If you invested $1000 in Repligen Corporation (RGEN) 10 years ago, it would be worth $2,976.31 as of July 15, 2025 at a share price of $118.1. Whereas If you bought $1000 worth of Repligen Corporation (RGEN) shares 5 years ago, it would be worth $901.73 as of July 15, 2025 at a share price of $118.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
GlobeNewswire Inc.
May 27, 2025 11:30 AM GMT
WALTHAM, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2024 Corporate Sustainability Report and rel
Repligen Corporation to Present at William Blair Growth Conference
GlobeNewswire Inc.
May 22, 2025 11:30 AM GMT
WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the William Blair 45th Annual Growth Stock
Repligen Corporation to Present at Upcoming May Investor Conferences
GlobeNewswire Inc.
May 07, 2025 11:30 AM GMT
WALTHAM, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences. RB